Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flickinger, E. A.
Right arrow Articles by Fahey, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flickinger, E. A.
Right arrow Articles by Fahey, G. C., Jr.
(Journal of Nutrition. 2000;130:1267-1273.)
© 2000 The American Society for Nutritional Sciences


Article

Glucose-Based Oligosaccharides Exhibit Different In Vitro Fermentation Patterns and Affect In Vivo Apparent Nutrient Digestibility and Microbial Populations in Dogs

Elizabeth A. Flickinger, Bryan W. Wolf*, Keith A. Garleb*, JoMay Chow*, Gregory J. Leyer*, Paul W. Johns* and George C. Fahey, Jr.1

Division of Nutritional Sciences and Department of Animal Sciences, University of Illinois, Urbana, IL 61801 * Ross Products Division, Abbott Laboratories, Columbus, OH 43215

1To whom correspondence should be addressed.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
To evaluate the potential of indigestible oligosaccharides (OS) to serve as "dietary fiber-like" ingredients, it is necessary to determine their extent of indigestibility. In vitro fermentation characteristics of two novel OS, {alpha}-glucooligosaccharides (GOS) and a maltodextrin-like OS (MD), were compared to those of fructooligosaccharides (FOS), gum arabic (GA), guar gum (GG) and guar hydrolysate (GH). Total short-chain fatty acid (SCFA) production (µmol/g dry matter) as a result of MD fermentation was higher initially compared with GA (P < 0.01), but GA was more extensively fermented at 24 h (P < 0.01). Total SCFA production for GOS was similar to that for FOS, GG, GH and GA. In the second experiment, GOS and MD were added at 6% to an enteral formula control diet (Control) and fed to ileal-cannulated dogs in a 3 x 3 replicated Latin-square design. Ileal digestibility of glucose was lower (P < 0.05) and carbohydrate (CHO) numerically lower (P = 0.08) for both GOS and MD compared with the Control. Total tract digestibility of CHO and glucose was lower only for MD (P < 0.01) compared with the Control. Total fecal weights were higher (P < 0.01) for both GOS and MD treatments. Fecal concentration of bifidobacteria was numerically increased by GOS and MD supplementation (P = 0.13 and 0.23, respectively). Thus, GOS and MD are indigestible yet fermentable OS, and may act as "dietary fiber-like" ingredients.


KEY WORDS: • oligosaccharides • fermentation • intestinal microbiota • short-chain fatty acids • dogs


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Many oligosaccharides (OS)2 are not hydrolyzed in the small intestine but are fermented rapidly in the lower gastrointestinal tract of humans and nonruminant animals. Gibson and Roberfroid (1995)Citation used the term "prebiotics" for certain nondigestible OS because they selectively stimulate favorable endogenous bacterial populations when supplemented in the diet at low levels. Both the fermentation process and the proliferation of favorable bacteria caused by OS ingestion can benefit the host animal. Oligosaccharides are fermented rapidly to yield short-chain fatty acids (SCFA), including butyrate, which is a fuel for colonocytes (Sakata 1987Citation ). Favorable bacterial populations, such as bifidobacteria, can promote health by inhibiting pathogenic bacteria such as Clostridium perfringens and Escherichia coli (Araya-Kojima et al. 1995Citation , Gibson and Wang 1994Citation ).

An {alpha}-glucooligosaccharide (GOS) was obtained through enzymatic synthesis from sucrose and maltose to yield a branched-chain ({alpha}-1,2, {alpha}-1,4 and {alpha}-1,6 linkages) glucose polymer with an average degree of polymerization of 5. Maltodextrin-like glucose-based oligosaccharides (MD) were produced by heat and enzymatic treatment of cornstarch, creating a random distribution of {alpha}- and ß- (1,4), (1,6), (1,2) and (1,3) linkages. It has an average molecular weight of 2000.

The objectives of this study were as follows: 1) to determine the in vitro fermentation characteristics of GOS and MD in reference to other fermentable oligosaccharides; 2) to determine the small intestinal digestibility of GOS and MD in ileal-cannulated dogs; and 3) to determine the effects of GOS and MD on fecal microbial populations in dogs.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
In vitro experiment

    Substrates and donors. Substrates used in this study were GOS (Bioecolians, Solabia, Pantin Cedex, France), MD (Fibersol 2E, Matsutani Chemical Industry, Hyogo, Japan), fructooligosaccharides (FOS) (NutraFlora, Golden Technologies, Westminister, CO), gum arabic (GA), guar gum (GG) (TIC Gums, Belcamp, MD), and hydrolyzed guar gum with 24,000 MW (GH) (Fiberon S, Dainippon, Japan). Three healthy adult male human donors (average age 30 y; average weight 78 kg) served as sources of fecal material from which the inoculum was prepared. The donors consumed a "Western" diet and no antibiotics in the 3 mo preceding the experiment.

    Design. Substrates were fermented in vitro for 24 h with fresh human fecal microflora obtained from each of three donors. The experiment was designed as a randomized complete block with the three fecal donors serving as blocks. Treatments were allotted in a 6 x 7 factorial arrangement with six substrates and seven incubation lengths. Each block by treatment combination was assayed using duplicate fermentation tubes. Duplicate tubes containing no substrate also were fermented with each inoculum source and time point to correct for SCFA not arising from the substrates.

    Fermentation. Aliquots (9 mL) of sterile anaerobic buffer (95% CO2/5% H2, pH 6.8) were aseptically transferred into tubes containing 75 mg substrate. Buffer composition is presented in Table 1Citation . To maintain anaerobic conditions, the tubes were sealed with butyl rubber stoppers in an anaerobic (95% CO2/5% H2) chamber. Substrates were hydrated for ~2 h before incubation.


View this table:
[in this window]
[in a new window]
 
Table 1. Composition of buffer used for in vitro fermentation1

 
Feces from the three donors were collected in commode specimen collection systems (Sage Products, Crystal Lake, IL). Immediately after collection, feces were diluted (1:10 wt/v) with anaerobic fermentation buffer. Substrate and blank tubes were then inoculated aseptically with 1 mL diluted feces. Tubes were incubated at 37°C, and 1.0 mL samples were collected at 0, 1.5, 3, 6, 11, 18 and 24 h.

    Chemical analyses. A 1-mL aliquot was removed for immediate pH determination before centrifuging at 13,000 x g at 22°C for 3 min. The supernatant was stored at -70°C. Acetate, propionate, butyrate and lactate concentrations in cell-free supernatant were analyzed by ion exclusion chromatography using a Hewlett Packard Model HP1090 Liquid Chromatograph equipped with an ION-300 ion exclusion column (30 cm x 7.8 mm i.d.) (Interaction Chemicals, Mountain View, CA). The mobile phase consisted of 0.005 mol/L H2SO4 with a flow rate of 0.3 mL/min and 40°C column temperature.

    Statistical analyses. Data were analyzed as a randomized complete block with fecal donor serving as the block. The model statement included donor, substrate, time and substrate x time. All analyses were performed according to the General Linear Models (GLM) procedure of SAS (1994)Citation . Arithmetic means are reported along with the SEM for all treatments. When treatment differences were detected (P < 0.05), means were compared by the least significant difference method (Carmer and Swanson 1973Citation ).

In vivo experiment

    Animals and diets. Six purpose-bred adult female dogs (Butler Farms USA, Clyde, NY) with hound bloodlines and an average weight of 25.3 ± 4.6 kg and age of 3 ± 1.5 y were surgically prepared with ileal cannulas. Ileal cannulation was conducted according to Walker et al. (1994)Citation . Dogs were housed individually in clean floor pens (1.2 x 3.1 m) in a temperature-controlled room at the animal facility of the Edward R. Madigan Laboratory on the University of Illinois campus. All dogs were allowed free access to water. The surgical and animal care procedures were approved by the Campus Laboratory Animal Care Advisory Committee, University of Illinois at Urbana-Champaign.

Two OS treatments were tested against a control: Enteral Control, Enteral Control + GOS (GOS), and Enteral Control + MD (MD). An enteral diet was selected as the control because it provided very highly digestible nutrients for the dogs, allowing a more exact test of the less digestible OS. The OS were added at the 6% level [dry matter (DM) basis] to the Control diet, such that they did not replace any individual dietary component. Diets were reconstituted before feeding by adding 235 g of Enteral Control powder to 835 mL H2O, or 249 g of the GOS or MD diets to 825 mL H2O.

The chemical composition of the experimental diets is reported in Table 2Citation . Dietary protein was provided as sodium caseinate, calcium caseinate and soy protein isolate. Corn oil was used as the sole lipid source, whereas corn syrup and sucrose comprised the carbohydrate portion of the diet. On an energy basis, the enteral diets supplied ~14% of kJ as protein, 31.5% as fat and 54.5% as carbohydrate.


View this table:
[in this window]
[in a new window]
 
Table 2. Chemical composition of diets fed to ileal cannulated dogs12

 
    Experimental design. Dogs were randomized in a replicated 3 x 3 Latin-square design with 14-d periods. Dogs were offered 1000 mL of the reconstituted diets at 0800 and 2000 h daily to provide ~8.37 MJ metabolizable energy/d. The diet adaptation phase consisted of d 1 through 10; d 11 through 14 were used for ileal and fecal collections. Chromic oxide was used as a digestion marker. On d 6 through 14 of each period, dogs were dosed with 0.5 g chromic oxide in a gelatin capsule at 0800 and 2000 h for a total of 1 g marker/d.

    Sampling procedures. During the collection phase, ileal effluent and feces were collected for 4 d. Ileal effluent was collected 3 times per day, with an interval of 4 h between collections. Individual ileal collections were 1 h in duration. Sampling times on the remaining 3 d were rotated 1 h from the previous day’s collection time. For example, on d 1, sampling took place at 0800, 1200 and 1600 h; on d 2, samples were collected at 0900, 1300 and 1700 h. Ileal samples were obtained by attaching a Whirlpak bag (Pioneer Container, Cedarburg, WI) to the cannula barrel and around the cannula hose clamp with a rubber band. Before attachment of the bag, the interior of the cannula was scraped clean with a spatula and initial digesta discarded. During collection of ileal effluent, dogs were encouraged to move around freely. The use of Elizabethan collars was necessary for some dogs to deter them from pulling the collection bag from their cannula. Total feces excreted during the collection phase of each period were collected from the floor of the pen, weighed, composited and frozen at -4°C.

    Sample handling. Ileal samples were frozen at -4°C in their individual bags. At the end of the experiment, all ileal effluent samples were composited for each dog for each period, and then refrozen at -4°C. Ileal effluent then was freeze-dried in a Tri-Philizer MP microprocessor-controlled lyophilizer (FTS Systems, Stone Ridge, NY). Feces were dried at 55°C in a forced-air oven. After drying, both feces and ileal samples were ground through a 2-mm screen in a Wiley mill (model 4, Thomas Scientific, Swedesboro, NJ). Diets were analyzed in the unhydrated powdered form.

Freshly voided feces were collected within 15 min of defecation; individual aliquots were immediately transferred to preweighed Carey-Blair transport media containers (Meridian Diagnostics, Cincinnati, OH) for subsequent bacterial enumeration. Feces were scored for each dog during each period according to the following system: 1 = hard, dry pellets, small, hard mass; 2 = hard, formed, dry stool, remains firm and soft; 3 = soft, formed, moist, softer than stool that retains shape; 4 = soft, unformed, stool assumes shape of container, pudding-like; 5 = watery; liquid that can be poured.

    Chemical analyses. Diets, feces and ileal effluent were analyzed for DM, organic matter (OM) and ash using AOAC (1984)Citation methods. Crude protein (CP) was calculated from Kjeldahl N values (AOAC 1984Citation ). Total lipid content was determined by acid hydrolysis followed by ether extraction according to the American Association of Cereal Chemists (1983)Citation and Budde (1952)Citation . Chromium was analyzed according to Williams et al. (1962)Citation using an atomic absorption spectrophotometer (Model 2380, Perkin-Elmer, Norwalk, CT). Carbohydrate (CHO) content was calculated as the difference between OM content and the sum of crude protein and lipid contents. Glucose content was determined by monosaccharide analysis according to Bourquin et al. (1990)Citation . Monosaccharides were hydrolyzed with H2SO4 and quantified by anion exchange HPLC with pulsed electrochemical detection. Briefly, 50 µL of each neutralized, hydrolyzed sample was injected into an HPLC fitted with a Dionex Carbo-Pac PA-1 column (250 x 4 mm) (Dionex, Sunnyvale, CA). Individual monosaccharides were eluted with degassed water (1.0 mL/min, ambient temperature) and 300 mmol/L NaOH was added postcolumn. For all laboratory analyses, samples were analyzed in duplicate, and analyses were repeated if a deviation > 5% between duplicates occurred.

Total anaerobes, total aerobes, bifidobacteria, lactobacilli and bacteroides spp. were determined by serial dilution of fecal samples in anaerobic diluent (Bryant and Burkey 1953Citation ) before inoculation onto respective petri dishes of sterile agar. Total anaerobe and total aerobe agars were prepared according to Bryant and Robinson (1961)Citation and Mackie et al. (1978)Citation . The selective medium for bifidobacteria (BIM-25) was prepared using reinforced clostridial agar (BBL Microbiology Systems, Cockeyville, MD) according to the method described by Muñoa and Pares (1988)Citation . Lactobacilli were cultured on Rogosa SL agar (Difco Laboratories, Detroit, MI). Bacteroides spp. were cultured on a trypticase yeast extract glucose agar listed in Table 3Citation . Plates were incubated anaerobically (95% CO2/5% H2) at 38°C. Colony forming units were defined as being distinct colonies measuring at least 1 mm in diameter.


View this table:
[in this window]
[in a new window]
 
Table 3. Composition of agar used to enumerate Bacteroides spp.

 
    Calculations. Dry matter (g/d) recovered as ileal effluent or excreted as feces was calculated by dividing the Cr intake (mg/d) by ileal or fecal Cr concentrations (mg Cr/g ileal effluent or feces), respectively. Ileal and fecal nutrient flows were calculated by multiplying the DM flow by the concentration of the nutrient in the ileal or fecal DM. Ileal and total tract nutrient digestibilities were calculated as nutrient intake (g/d) minus the ileal or fecal nutrient flow (output, g/d), divided by nutrient intake (g/d).

    Statistical analysis. Data were analyzed by the General Linear Models procedure of SAS (1994)Citation . The experimental design was a replicated 3 x 3 Latin square. Six sequences of the diets (one sequence per dog) were used (ABC, CAB, BCA, ACB, BAC, CBA), where A was Enteral Control, B was Enteral Control + GOS, and C was Enteral Control + MD. Model sums of squares were separated into treatment, period and animal effects. When significant (P < 0.05) differences were detected, treatment means were compared by the least significant difference method of SAS (Carmer and Swanson 1973Citation ).


    RESULTS AND DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
In vitro experiment

    pH values. In general, pH decreased as time of fermentation increased (Fig. 1Citation ). All substrates had similar pH values (6.9) at 0 h. Fructooligosaccharide fermentation resulted in the most rapid decline in pH and the lowest pH values (P < 0.05) at 3 and 6 h. Conversely, GA had the slowest decline in pH and the highest pH values (P < 0.05) at 1.5, 3, 6 and 11 h of fermentation. The pH values for GOS, GH, GG and MD generally were intermediate to that of FOS and GA between 0 and 6 h. However, at 24 h, GOS had a numerically lower pH (P = 0.18) than FOS and a lower pH (P < 0.05) than all other substrates. The pH decline for MD was rapid from 0 to 3 h, but then was relatively stable. At 24 h, the highest (P < 0.05) pH value was noted for MD (6.31) compared with all other substrates. Overall, the pH declines for GOS, FOS, GH and GG were not different (P = 0.35) from those of MD and GA.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 1. The pH values of substrates after different times of in vitro fermentation. Values are means, n = 6. Asterisks indicate a significant difference from all other means at that time, P < 0.05. FOS, fructooliogsaccharide; GOS, {alpha}-glucooligosaccharide; GH, hydrolyzed guar gum; GG, guar gum; MD, maltodextrin-like glucose-based oligosaccharide; GA, gum arabic.

 
    Organic acid production. Organic acid (acetate + propionate + butyrate + lactate) concentrations increased over time (Table 4Citation). Fructooligosaccharides resulted in the most rapid accumulation of organic acids, achieving 93% of total organic acid production after only 6 h. However, by 11 h, FOS, GOS, GH and GG had similar concentrations of organic acids. Gum arabic resulted in the lowest (P < 0.05) organic acid concentrations at 11 h, and MD was intermediate. After 24 h of fermentation, GOS resulted in the numerically highest (P = 0.15) organic acid concentration, whereas MD had the lowest (P < 0.05). Fermentation of GA, GG, GH and FOS resulted in intermediate organic acid concentrations, which were not significantly different from values obtained for GOS.


View this table:
[in this window]
[in a new window]
 
Table 4. Acetate, propionate, butyrate and total organic acid accumulation after different hours of in vitro fermentation of substrates1

 
After 6 or 11 h of fermentation, GOS and FOS resulted in the highest (P < 0.05) concentrations of acetate. Hydrolyzed guar gum, GG and MD had intermediate concentrations of acetate. Gum arabic resulted in the lowest (P < 0.05) concentrations of acetate at 6 and 11 h. At 6 h, propionate concentration was numerically lowest (P = 0.11) for GA compared with all other substrates. At 11 h, propionate concentration was highest (P < 0.05) for GG, and remained lowest (P < 0.05) for GA. Fructooligosaccharide and GOS were intermediate in propionate concentration after 11 h of fermentation. Butyrate concentrations at 6 or 11 h were numerically highest (P = 0.23) for FOS and were lowest (P < 0.05) for GA. At 6 and 11 h, GOS, GH and GG had intermediate concentrations of butyrate.

In contrast to the 11-h observation, after 24 h of fermentation, the concentration of acetate for GA was greater than FOS (P < 0.05) and numerically greater than GOS (P = 0.10) (Table 4)Citation . The concentration of acetate produced by GOS remained greater (P < 0.05) than that of MD, which was similar to the values for GG, GH and FOS. After 24 h of incubation, propionate concentration was numerically lowest (P = 0.15) for FOS (Table 4)Citation . Butyrate accumulation was greater (P < 0.05) for FOS, GOS, GH and GG, than for MD and GA (Table 4)Citation after 18 and 24 h of incubation. The highest butyrate-producing substrates resulted in ~5–35 times greater values compared with the lowest butyrate-producing substrates after 11–24 h of fermentation. Relatively little lactate accumulated, and none was detected after 6 h of fermentation (data not shown). Fructooligosaccharides had the highest (P < 0.05) concentrations of lactate at 3 and 6 h of fermentation. No lactate accumulated as a result of the fermentation of GG or GA.

The more rapid pH decline and organic acid production as a result of FOS and GOS fermentation indicated that these two OS were fermented more rapidly than the other substrates tested in this study. Maltodextrin-like oligosaccharides resulted in the lowest in vitro production of organic acids and the highest pH at 24 h, indicating some resistance to fermentation. Short-chain fatty acid profiles, in addition to concentrations, varied among substrates. Butyrate production was highest and similar for FOS, GOS, GH and GG. Butyrate is a major fuel for colonocytes (Roediger 1980Citation ) and has been demonstrated to stimulate epithelial cell proliferation (Sakata 1987Citation ). Therefore, substrates that produce high levels of butyrate, such as FOS, GOS, GG and GH, may provide similar beneficial effects when included in diets. The rapid in vitro accumulation of butyrate with FOS fermentation at 6 h indicates that FOS would serve as an excellent source of butyrate in vivo. On the other hand, the slower rate of fermentation of GA and MD indicates that they would perhaps provide a source of fermentable CHO to the more distal part of the large intestine. A blend of rapidly and slowly fermented carbohydrates should result in production of SCFA throughout the large intestine.

In vivo experiment

    Chemical composition. The chemical composition of the diets is reported in Table 2Citation . Dry matter, OM, CP, fat, glucose and CHO content did not differ among diets.

    Nutrient intake and apparent digestibility. Intakes of DM, OM and CP did not differ (Table 5Citation). Fat intake was lower (P < 0.05) for the Control treatment than for either the GOS or MD treatments due to lower DM intakes. Dogs consuming either the GOS- or MD-containing diets had greater (P < 0.05) glucose and numerically greater (P = 0.09) CHO intakes compared with the Control diet. This was expected because GOS and MD were added at 6% "on top" of the control diet.


View this table:
[in this window]
[in a new window]
 
Table 5. Nutrient intakes and apparent digestibility data for ileal-cannulated dogs fed diets supplemented with {alpha}-glucooligosaccharide (GOS) or maltodextrin-like glucose-based oligosaccharide (MD)

 
Ileal digestibility of DM, OM, CP and fat did not differ among treatments. Although the overall model was not significant (P = 0.12), ileal digestibility of glucose was significantly different (P < 0.05) due to diet. Ileal glucose digestibility values were 4.6 and 4.8 percentage units lower for both the GOS- and the MD-containing treatments, respectively, compared with the Control diet. Diet tended (P = 0.08) to reduce ileal digestibility of CHO (5.5 and 4.3 percentage units lower) compared with the Control diet. These data indicate that the supplemental OS, GOS and MD resisted hydrolytic digestion and passed intact into the large intestine. These results are supported by data of Valette et al. (1993)Citation who demonstrated that GOS was ~20% digested by germfree rats. Furthermore, Tsuji and Gordon (1998)Citation reported that MD disappearance was only 10% after four consecutive in vitro incubations with salivary {alpha}-amylase, gastric juice, pancreatic {alpha}-amylase and reconstituted intestinal mucosa, which simulated hydrolytic digestion.

Total tract digestibilities of DM and fat did not differ among treatments. Crude protein digestibility was lower (P < 0.05) for dogs consuming the GOS and MD treatments. The lower values for total tract digestibility of the GOS and MD diets may be attributed to an increased fecal excretion of microbial protein. Wolf et al. (1998)Citation proposed that as the percentage of fermentable carbohydrate increases in the diet, the amount of microbial mass increases in the feces. This would result in an increase in fecal N excretion and an apparent decrease in crude protein digestibility. Organic matter, carbohydrate and glucose digestibilities were lower (P < 0.05) for the MD treatment compared with either the Enteral Control or the GOS treatments. This may indicate that MD was not completely fermented in the large intestine as suggested by our in vitro study. Incomplete fermentation also was reported by Tsuji and Gordon (1998)Citation , who recovered 38% of orally dosed MD in the feces of adult rats. There was a trend for carbohydrate and glucose digestibility to be slightly lower for the GOS diet compared with the Control. This suggests that GOS was extensively fermented. These findings agree with those of Djouzi et al. (1995)Citation who demonstrated that GOS was fermented extensively by human intestinal bacterial strains in vitro and in vivo by trixenic rats associated with Bacteroides thetaiotaomicron, Bifidobacterium breve and Clostridium butyricum.

    Fecal weight, fecal score, and body weight changes. There were no differences among treatments in body weight changes of dogs (data not shown). Fecal weights for dogs consuming the GOS diet were greater (P < 0.05) than those of the Control on an as-is basis and tended (P = 0.07) to be greater on a DM basis (Table 6Citation). Fecal weight, on both an as-is and DM basis, was greater (P < 0.05) for dogs consuming the MD treatment compared with the Control. On a DM basis, the fecal weight for MD was greater (P < 0.05) than that of GOS. These data, along with the high 24-h pH value for MD after 24 h of in vitro fermentation, indicate that it is not completely fermented by the colonic microflora of dogs or humans. Increased fecal weight is a common outcome of dietary fiber consumption. Depending on its individual characteristics, dietary fiber can increase fecal bulk by increasing bacterial cell mass, undegraded fiber residue, fecal water or a combination of these effects (Fahey et al. 1990Citation , Roberfroid 1993Citation , Schneeman, 1987Citation ). Fecal scores were higher (P < 0.05) for dogs consuming the GOS and MD treatments compared with the Control, indicating a higher fecal moisture content. Overall, the fecal scores were relatively high. The loosely formed stools were caused in part by consumption of an enteral formula. Increased fecal moisture content is a common effect attributed to dietary fiber. Fecal water content can be increased by the physical water-holding properties of fibers, and possibly by the osmotic action of SCFA produced by fermentation (Roberfroid 1993Citation , Schneeman 1987Citation ).


View this table:
[in this window]
[in a new window]
 
Table 6. Fecal characteristics of ileal-cannulated dogs fed diets supplemented with {alpha}-glucooligosaccharide (GOS) or maltodextrin-like glucose-based oligosaccharide (MD)

 
    Fecal bacterial concentrations. There were no significant (P > 0.05) differences in bacterial concentrations among treatments (Table 7Citation ). However, trends were apparent. The concentrations of total anaerobes were increased slightly by the addition of GOS or MD to the basal diet. Bifidobacteria concentrations also tended to increase when GOS or MD were added to the diet (P = 0.13 and 0.23, respectively). Bacteroides concentrations were numerically lower (P = 0.10) for the MD diet compared with the Control. These results agree with data collected by Kohmoto et al. (1988)Citation , who reported that dietary isomaltooligosaccharides (13.5 g/d for 14 d) increased fecal bifidobacteria levels (P < 0.05) in healthy adult males.


View this table:
[in this window]
[in a new window]
 
Table 7. Fecal bacterial concentrations for cannulated dogs fed diets supplemented with {alpha}-glucooligosaccharide (GOS) or maltodextrin-like glucose-based oligosaccharide (MD)1

 
Total anaerobes and total aerobes indicate general fermentative activity, whereas bifidobacteria and lactobacilli are indicators of a more remedial, beneficial bacterial population. Increased concentrations of bifidobacteria and lactobacilli have been associated with decreased fecal concentrations of potentially pathogenic bacteria (Araya-Kojima et al. 1995Citation , Gibson and Wang, 1994Citation ) and decreased levels of carcinogenic and putrefactive compounds (Hara et al. 1994Citation , Mitsuoka 1982Citation , Terada et al. 1992Citation ). Although these compounds were not measured in this study, the bifidogenic effect of GOS and MD also may reduce fecal putrefactive compounds.

Bacteroides are the predominant colonic bacterial genera, comprising ~30% of the total culturable microflora (Macfarlane and Macfarlane 1995Citation ). Most bacteroides are considered neither beneficial nor detrimental to host health. They readily utilize resistant starch as well as nonstarch polysaccharides (Hudson and Marsh, 1995Citation ). In our experiment, GOS and MD led to a numerical increase in fecal concentrations of bacteroides.

Ileal-cannulated dogs were chosen as the animal model for this study for the many similarities they share with humans. Both dogs and humans are omnivorous monogastrics. Like humans, dogs have numerous species of endogenous bacteria in their lower gastrointestinal tract (Balish et al. 1977Citation , Davis et al. 1977Citation ) that contribute to significant amounts of colonic fermentation (Banta et al. 1979Citation ). The microflora of both dogs and humans contains bacteroides, bifidobacteria and lactobacilli as predominant species (Davis et al. 1977Citation , Gibson and Roberfroid 1995Citation ). Dogs have been employed in numerous studies pertaining to human nutrition (Diez et al. 1997Citation and 1998Citation , Willard et al. 1994Citation ). The ileal-cannulated dog model has been widely used to evaluate ileal digestibility of nutrients in many types of ingredients (Muir et al. 1996Citation ; Murray et al. 1997Citation and 1998Citation , Zuo et al. 1996Citation ). Therefore, the ileal-cannulated dog is an appropriate model to utilize in evaluating oligosaccharides with potential human applications.

The in vitro and in vivo studies provided complementary data regarding the fermentation of the novel OS, GOS and MD. In vitro, the fermentation of GOS resulted in rapid production of high concentrations of SCFA, whereas MD fermentation resulted in a more gradual and overall lower SCFA production. In vivo, GOS and MD resisted hydrolytic digestion and were present at the terminal ileum. {alpha}-Glucooligosaccharide appears to be extensively fermented because very little was recovered in feces. However, MD was fermented only partially, resulting in significantly lower total tract CHO and glucose digestibility values.

In conclusion, both GOS and MD appear to be indigestible in the small intestine, supplying CHO to the large intestine for bacterial fermentation. Both in vitro and in vivo digestibility data suggest that GOS was fermented more extensively than MD. Dietary supplementation of these OS at the 6% level in an enteral formula did not greatly alter the digestibility of macronutrients. Both GOS and MD increased the volume of feces excreted and the moisture content of the feces. These OS also tended to increase fecal concentrations of beneficial bacteria, including bifidobacteria. These findings indicate that GOS and MD are indigestible in the upper intestinal tract. However, these OS may serve as fermentable dietary fiber-like substrates and positively affect gastrointestinal tract health.


    FOOTNOTES
 
2 Abbreviations used: CHO, carbohydrate; CP, crude protein; DM, dry matter; FOS, fructooligosaccharide; GA, gum arabic; GG, guar gum; GH, hydrolyzed guar gum; GOS; {alpha}-glucooligosaccharide; MD, maltodextrin-like glucose-based oligosaccharide; OM, organic matter; OS, oligosaccharide; SCFA, short-chain fatty acids. Back

Manuscript received October 14, 1999. Initial review completed December 9, 1999. Revision accepted February 1, 2000.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 

1. American Association of Cereal Chemists Approved Methods 8th ed. 1983 AACC St. Paul, MN.

2. Araya-Kojima T., Yaeshima T., Ishibashi N., Shimamura S., Hayasawa H. Inhibitory effects of Bifidobacterium longum BB536 on harmful intestinal bacteria. Bifidobacteria Microflora 1995;14:59-66

3. Association of Official Analytical Chemists Official Methods of Analysis 14th ed. 1984 AOAC Washington, DC.

4. Balish E., Cleven D., Brown J., Yale C. E. Nose, throat, and fecal flora of beagle dogs housed in "locked" or "open" environments. Appl. Environ. Microbiol. 1977;34:207-221[Abstract/Free Full Text]

5. Banta C. A., Clemens E. T., Krinsky M. M., Sheffy B. E. Sites of organic acid production and patterns of digesta movement in the gastrointestinal tract of dogs. J. Nutr. 1979;109:1592-1600

6. Bourquin L. D., Garleb K. A., Merchen N. R., Fahey G. C., Jr Effects of intake and forage level on site and extent of digestion of plant cell wall monomeric components by sheep. J. Anim. Sci. 1990;68:2479-2495[Abstract]

7. Bryant M. P., Burkey L. A. Cultural methods and some characteristics of some of the more numerous groups of bacteria in the bovine rumen. J. Dairy Sci. 1953;36:205-217[Abstract/Free Full Text]

8. Bryant M. P., Robinson I. M. An improved nonselective culture medium for ruminal bacteria and its use in determining diurnal variation in numbers of bacteria in the rumen. J. Dairy Sci. 1961;44:1446-1456[Abstract/Free Full Text]

9. Budde E. F. The determination of fat in baked biscuit type of dog foods. J. Assoc. Off. Agric. Chem. 1952;35:799-805

10. Carmer S. G., Swanson M. R. An evaluation of ten pair-wise multiple comparison procedures by Monte Carlo methods. J. Am. Stat. Assoc. 1973;68:66-74

11. Davis C. P., Cleven D., Balish E., Yale C. E. Bacterial association in the gastrointestinal tract of beagle dogs. Appl. Environ. Microbiol. 1977;34:194-206[Abstract/Free Full Text]

12. Diez M., Hornick J.-L., Baldwin P., Istasse L. Influence of a blend of fructo-oligosaccharides and sugar beet fiber on nutrient digestibility and plasma metabolite concentrations in healthy beagles. Am. J. Vet. Res. 1997;58:1238-1242[Medline]

13. Diez M., Hornick J.-L., Baldwin P., Van Eenaeme C., Istasse L. The influence of sugar-beet fibre, guar gum and inulin on nutrient digestibility, water consumption and plasma metabolites in healthy beagle dogs. Res. Vet. Sci. 1998;64:91-96[Medline]

14. Djouzi Z., Andrieux C., Pelenc V., Somarriba S., Popot F., Paul F., Monsan P., Szylit O. Degradation and fermentation of {alpha}-gluco-oligosaccharides by bacterial strains from human colon: in vitro and in vivo studies in gnotobiotic rats. J. Appl. Bacteriol. 1995;79:117-127[Medline]

15. Fahey G. C., Jr, Merchen N. R., Corbin J. E., Hamilton A. K., Serbe K. A., Hirakawa D. A. Dietary fiber for dogs:II. Iso-total dietary fiber (TDF) additions of divergent fiber sources to dog diets and their effects on nutrient intake, digestibility, metabolizable energy and digesta mean retention time. J. Anim. Sci. 1990;68:4229-4235[Abstract]

16. Gibson G. R., Roberfroid M. R. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995;125:1401-1412

17. Gibson G. R., Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J. Appl. Bacteriol. 1994;77:412-420[Medline]

18. Hara H., Li S.-T., Sasaki M., Maruyama T., Terada A., Ogata Y., Fujita K., Ishigami H., Hara K., Fujimori I., Mitsuoka T. Effective dose of lactosucrose on fecal flora and fecal metabolites of humans. Bifidobacteria Microflora 1994;13:51-63

19. Hudson M. J., Marsh P. D. Carbohydrate metabolism in the colon. Gibson G. R. Macfarlane G. T. eds. Human Colonic Bacteria: Role in Nutrition, Physiology, and Pathology 1995:73-85 CRC Press Boca Raton, FL.

20. Kohmoto T., Fukui F., Takaku H., Machida Y., Arai M., Mitsuoka T. Effect of isomalto-oligosaccharides on human fecal flora. Bifidobacteria Microflora 1988;7:61-69

21. Macfarlane S., Macfarlane G. T. Proteolysis and amino acid fermentation. Gibson G. R. Macfarlane G. T. eds. Human Colonic Bacteria: Role in Nutrition, Physiology, and Pathology 1995:75-85 CRC Press Boca Raton, FL.

22. Mackie R. I., Gilchrist M. C., Robberts A. M., Hannah P. E., Schwartz H. M. Microbiological and chemical changes in the rumen during the stepwise adaptation of sheep to high concentrate diets. J. Agric. Sci. (Camb.) 1978;90:241-254

23. Mitsuoka T. Recent trends in research on intestinal flora. Bifidobacteria Microflora 1982;1:3-24

24. Muir H. E., Murray S. M., Fahey G. C., Jr, Merchen N. R., Reinhart G. A. Nutrient digestion by ileal cannulated dogs as affected by dietary fibers with various fermentation characteristics. J. Anim. Sci. 1996;74:1641-1648[Abstract]

25. Muñoa F. J., Pares R. Selective medium for isolation and enumeration of Bifidobacterium spp. Appl. Environ. Microbiol. 1988;54:1715-1718[Abstract/Free Full Text]

26. Murray S. M., Patil A. R., Fahey G. C., Jr, Merchen N. R., Hughes D. M. Raw and rendered animal by-products as ingredients in dog diets. J. Anim. Sci. 1997;75:2497-2505[Abstract/Free Full Text]

27. Murray S. M., Patil A. R., Fahey G. C., Jr, Merchen N. R., Wolf B. W., Lai C.-S., Garleb K. A. Apparent digestibility of a debranched amylopectin-lipid complex and resistant starch incorporated into enteral formulas fed to ileal-cannulated dogs. J. Nutr. 1998;128:2032-2035[Abstract/Free Full Text]

28. Roberfroid M. Dietary fiber, inulin, and oligofructose: A review comparing their physiological effects. Crit. Rev. Food Sci. Nutr. 1993;33:103-148[Medline]

29. Roediger W.E.W. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980;21:793-798[Abstract/Free Full Text]

30. Sakata T. Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: A possible explanation for trophic effects of fermentable fibre, gut microbes and luminal trophic factors. Br. J. Nutr. 1987;58:95-103[Medline]

31. SAS Institute Inc. (1994) SAS/STAT User’s Guide, Version 6.10. SAS Institute, Cary, NC.

32. Schneeman B. O. Soluble vs insoluble fiber—different physiological responses. Food Technol 1987;41:81-82

33. Terada A., Hara H., Oishi T., Matsui S., Mitsuoka T., Nakajyo S., Fujimori I., Hara K. Effect of dietary lactosucrose on faecal flora and faecal metabolites of dogs. Microb. Ecol. Health Dis. 1992;5:87-92

34. Tsuji K., Gordon D. T. Energy value of a mixed glycosidic linked dextrin determined in rats. J. Agric. Food Chem. 1998;46:2253-2259

35. Valette P., Pelenc V., Djouzi Z., Andrieux C., Paul F., Monsan P., Szylit O. Bioavailability of new synthesized glucooligosaccharides in the intestinal tract of gnotobiotic rats. J. Sci. Food Agric. 1993;62:121-127

36. Walker J. A., Harmon D. L., Gross K. L., Collings G. F. Evaluation of nutrient utilization in the canine using the ileal cannulation technique. J. Nutr. 1994;124:2672S-2676S

37. Willard M. D., Simpson R. P., Delles E. K., Coben N. D., Fossum T. W., Kolp D., Reinhart G. Effects of dietary supplementation of fructo-oligosaccharides on small intestinal bacterial overgrowth in dogs. Am. J. Vet. Res. 1994;55:654-659[Medline]

38. Williams C. H., David D. J., Iismaa O. The determination of chromic oxide in faeces samples by atomic absorption spectrophotometry. J. Agric. Sci. (Camb.) 1962;59:381-385

39. Wolf B. W., Firkins J. L., Zhang X. Varying dietary concentrations of fructooligosaccharides affect apparent absorption and balance of minerals in growing rats. Nutr. Res. 1998;10:1791-1806

40. Zuo Y., Fahey G. C., Jr, Merchen N. R., Bajjalieh N. L. Digestion responses to low oligosaccharide soybean meal by ileally-cannulated dogs. J. Anim. Sci. 1996;74:2441-2449[Abstract]




This article has been cited by other articles:


Home page
J ANIM SCIHome page
P. Liu, X. S. Piao, S. W. Kim, L. Wang, Y. B. Shen, H. S. Lee, and S. Y. Li
Effects of chito-oligosaccharide supplementation on the growth performance, nutrient digestibility, intestinal morphology, and fecal shedding of Escherichia coli and Lactobacillus in weaning pigs
J Anim Sci, October 1, 2008; 86(10): 2609 - 2618.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. Goda, Y. Kajiya, K. Suruga, H. Tagami, and G. Livesey
Availability, fermentability, and energy value of resistant maltodextrin: modeling of short-term indirect calorimetric measurements in healthy adults
Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1321 - 1330.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
M. T. Liong and N. P. Shah
Effects of a Lactobacillus casei Synbiotic on Serum Lipoprotein, Intestinal Microflora, and Organic Acids in Rats
J Dairy Sci, May 1, 2006; 89(5): 1390 - 1399.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
M. T. Liong and N. P. Shah
Optimization of Cholesterol Removal by Probiotics in the Presence of Prebiotics by Using a Response Surface Method
Appl. Envir. Microbiol., April 1, 2005; 71(4): 1745 - 1753.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
M. R. Smiricky-Tjardes, E. A. Flickinger, C. M. Grieshop, L. L. Bauer, M. R. Murphy, and G. C. Fahey Jr.
In vitro fermentation characteristics of selected oligosaccharides by swine fecal microflora
J Anim Sci, October 1, 2003; 81(10): 2505 - 2514.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. J. Correa-Matos, S. M. Donovan, R. E. Isaacson, H. R. Gaskins, B. A. White, and K. A. Tappenden
Fermentable Fiber Reduces Recovery Time and Improves Intestinal Function in Piglets Following Salmonella typhimurium Infection
J. Nutr., June 1, 2003; 133(6): 1845 - 1852.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
L. A. White, M. C. Newman, G. L. Cromwell, and M. D. Lindemann
Brewers dried yeast as a source of mannan oligosaccharides for weanling pigs
J Anim Sci, October 1, 2002; 80(10): 2619 - 2628.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Zentek, B. Marquart, and T. Pietrzak
Intestinal Effects of Mannanoligosaccharides, Transgalactooligosaccharides, Lactose and Lactulose in Dogs
J. Nutr., June 1, 2002; 132(6): 1682S - 1684.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. M. Burkhalter, N. R. Merchen, L. L. Bauer, S. M. Murray, A. R. Patil, J. L. Brent Jr., and G. C. Fahey Jr.
The Ratio of Insoluble to Soluble Fiber Components in Soybean Hulls Affects Ileal and Total-Tract Nutrient Digestibilities and Fecal Characteristics of Dogs
J. Nutr., July 1, 2001; 131(7): 1978 - 1985.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flickinger, E. A.
Right arrow Articles by Fahey, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flickinger, E. A.
Right arrow Articles by Fahey, G. C., Jr.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2000 by American Society for Nutrition